CD81 and neoplasm: In addition, Cd81+migcDC1 also expressed high levels of Ccl22, which has been shown to promote the interaction with Tregs (9) and CCL22 was also increased at the protein level in the tumor upon 9 days of Flt3L treatment (Figures 3D, S5A, E).